The money will pay for efforts to prevent and treat opioid addiction, or fund services that help people in recovery.

Purdue has sold a Narcan alternative since 2022 and Hikma has developed an opioid antagonist twice the dose of Narcan.

Sen. Mike Yakawich's bill to prohibit the state from buying overdose reversal drugs from companies that settled with states ...

Billings, compares the state’s purchase of overdose reversal drugs like Narcan from companies that have contributed to the ...

For those most impacted and waiting for justice, 2025 can be a year of accountability. Here are two databases to track the settlement money ...

Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...

Last week’s settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is ...

The deal, agreed to by Purdue Pharma, the Sackler family members who own the company and lawyers representing state and local ...

The freeze also prohibited the publication of scientific studies and research reports, including the CDC’s Morbidity and Mortality Weekly Report. KFF Health News reported that – until now – the ...

Pennsylvania looks likely to receive another big infusion of money from another court settlement over responsibility for the nation’s ongoing opioid epidemic. If the settlement is finalized, it will ...